Spinal Muscular Atrophy (SMA)

Overview and management of SMA.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
NeurologyGenetics

Clinical Guidelines

NICE guideline [HST15]: Onasemnogene abeparvovec for treating spinal muscular atrophy
National
NICE guideline [TA755]: Risdiplam for treating spinal muscular atrophy
National
NICE highly specialised technologies guidance [HST15]: Onasemnogene abeparvovec for treating spinal muscular atrophy
National
NICE technology appraisal guidance [TA755]: Risdiplam for treating spinal muscular atrophy
National
218th ENMC International Workshop: Revisiting the consensus on standards of care in SMA
Local
ACOG Practice Bulletin No. 78: Spinal Muscular Atrophy (SMA) Carrier Testing
Local
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
Local
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
Local
Diagnosis and management of spinal muscular atrophy: Part 1. Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
Local